Veterinary Healthcare Global Market Briefing 2020: Covid 19 Impact and Recovery

Veterinary Healthcare Global Market Briefing 2020: Covid 19 Impact and Recovery

The global veterinary healthcare market is expected to remain stable from $150.6 billion to $151.2 billion in 2020 at a CAGR of 0.39%, despite the disruption in supply chains as a result of trade restrictions and lockdowns imposed across countries owing to the COVID-19 outbreak. The market is then expected to recover and grow at a CAGR of 5.52% from 2020 to reach $177.6 billion in 2023.

Veterinary Healthcare Global Market Briefing 2020: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global veterinary healthcare sector.

Reasons to Purchase

Fully updated for 2020 including the impact of the Covid 19/ Novel Coronavirus.
Identify growth segments and opportunities.
Facilitate decision making on the basis of historic and forecast data and key trends
Develop strategies based on likely future developments.
Gain a global perspective on the development of the market.

Description

Veterinary Healthcare Global Market Briefing 2020: Covid 19 Impact and Recovery from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the veterinary healthcare market revenues, covering both the historic growth of the market and forecasting the future.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

The trends and strategies section highlights the likely future developments in the veterinary healthcare market and suggests approaches.

Scope

Markets Covered: Veterinary Healthcare; Animal Medicine; Veterinary Medical Equipment

Companies: Zoetis, Inc.; Boehringer Ingelheim GmbH; Merck & Co; Henry Schein, Inc.; Eli Lilly And Company

Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa

Countries: Australia, China, Hong Kong, India, Indonesia, Japan, South Korea, Malaysia, New Zealand, Philippines, Singapore, Thailand, Vietnam, Canada, USA, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela, Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, the UK, Czech Republic, Poland, Romania, Russia, Israel, Saudi Arabia, Turkey, UAE, Egypt, Nigeria, South Africa

Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.